QPS Blog
Featuring news and insights on QPS’ and its Clients’ efforts in providing patients with novel, safe, effective and affordable medicines
Three QPS Posters on Display at the upcoming ISSX Meeting
dateOctober 15, 2015
dateZamas Lam, Senior Vice President Preclinical Development

Come review and discuss the latest xenobiotic research with us in person. Top QPS scientists will be at the 20th North American ISSX Meeting next week in Orlando, Florida, where they'll display three posters with contributions from QPS. We're looking forward to answering your questions and hearing your thoughts about our findings. The posters below will be on display in the Exhibit Hall (Bonnet Creek I – IX) at the Hilton Orlando Bonnet Creek Resort, Monday, Oct. 19 through Wednesday, Oct. 21. See you soon!

Poster P54:
CROSS VALIDATION OF DRUG DISTRIBUTION DETECTED UTILIZING IMAGING MALDI MASS SPECTROMETRY AND QUANTITATIVE AUTORADIOGRAPHY
Cristine M. Quiason1, Xingrong Liu1, Eric Solon2 and Sheerin K. Shahidi-Latham1
1Department of Drug Metabolism & Pharmacokinetics, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, 2QPS, LLC., Delaware Technology Park, 3 Innovation Way, Suite 240 Newark, DE 19711

Poster P195:
IDENTIFY, PROFILE, AND RADIO QUANTITATE THE METABOLITES OF [14C]NEFOPAM IN MALE AND FEMALE RATS AFTER A SINGLE ORAL ADMINISTRATION
Jian Yu1, Eric Solon1, Helen Shen1, Zamas Lam1 and Aravind Mittur2
1DMPK Department, QPS, Newark, DE 19711, 2Impax Specialty Pharma, Hayward, CA 94544

Poster P59:
EXCRETION MASS BALANCE, PHARMACOKINETICS, AND TISSUE DISTRIBUTION OF [14C] NEFOPAM HYDROCHLORIDE FOLLOWING A SINGLE ORAL ADMINISTRATION IN WISTAR HAN AND LONG-EVANS RATS
Eric Solon1, and Helen Shen1 and Aravind Mittur2
1DMPK Department, QPS, LLC, Newark, Delaware, 2Impax Specialty Pharma, Hayward, CA94544

back

top